Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/04/1994 | US5352690 For asthma, allergies |
10/04/1994 | US5352688 Methods for the treatment of bradyphrenia in parkinson's disease |
10/04/1994 | US5352687 Substituted phenylacetamides |
10/04/1994 | US5352686 Method for producing an orexigenic effect |
10/04/1994 | US5352685 Gastrointestinal disorders |
10/04/1994 | US5352684 Antitumor, anticarcinogenic agents |
10/04/1994 | US5352683 Administering N-methyl-D-aspartate receptor antagonist |
10/04/1994 | US5352682 Compositions containing salts of bile acid-aminosalicylate conjugates |
10/04/1994 | US5352681 Pharmaceutical enema preparation |
10/04/1994 | US5352680 Delta opioid receptor antagonists to block opioid agonist tolerance and dependence |
10/04/1994 | US5352679 Use of rifaximin and pharmaceutical formulations containing it in the treatment of gastric dyspepsia caused by helicobacter pylori |
10/04/1994 | US5352678 Antiischemic piperazinyl- and piperidinyl-cyclohexanes |
10/04/1994 | US5352677 Cinnamamide derivative |
10/04/1994 | US5352676 Morphalinomethyl-substituted 1-phenyl-indero-[1,2-c]pyrazol-3-yl derivatives of 2-cyano-3-oxo-propanamides useful in the treatment of rheumatoid arthritis |
10/04/1994 | US5352673 Prodrugs |
10/04/1994 | US5352670 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
10/04/1994 | US5352669 Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment |
10/04/1994 | US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them |
10/04/1994 | US5352460 Blending powders of bile salt, buffer, adhesive polymer, disintegrant, wetting, granulating or extruding, compacting uniform particles to spheres, drying, sorting, coating with acid resistant polymer, drying |
10/04/1994 | US5352442 Topical tempo |
10/04/1994 | US5352440 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof |
10/04/1994 | US5352438 Anti-free radical topical composition based on dismutase superoxide and a phosphonic derivative |
10/04/1994 | US5351991 Folded sheet means |
10/04/1994 | CA1332239C Tetrazole excitatory amino acid receptor antagonists |
10/04/1994 | CA1332238C 4h-1-benzopyran-4-one derivatives, a process for their preparation and their use as medicaments |
10/04/1994 | CA1332237C N-sulphonamidoethyl-indolylpropionic acids and use thereof to inhibit thrombocyte aggregation |
10/04/1994 | CA1332236C ,--diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides |
10/04/1994 | CA1332234C Synthetic receptor analogues |
10/04/1994 | CA1332228C Formulation and method for estrogen replacement therapy |
10/04/1994 | CA1332227C Oral contraceptive formulation |
10/03/1994 | CA2120300A1 Pharmaceutical use of pyridoxal derivative |
10/03/1994 | CA2118985A1 Heterocyclic inhibitors of farnesyl protein transferase |
10/02/1994 | CA2120301A1 Thiadiazinones |
10/01/1994 | CA2120203A1 1,2,5,6-tetrahydropyridine derivative, process for preparing it and its applications in therapy |
10/01/1994 | CA2120192A1 Hiv protease inhibitors useful for the treatment of aids |
10/01/1994 | CA2119732A1 Stereocontrolled synthesis of cis-bicyclic compounds |
10/01/1994 | CA2119730A1 Synthesis of cis-decahydroisoquinoline-3-carboxylic acids |
10/01/1994 | CA2116198A1 Lipid metabolism improving medicinal composition |
10/01/1994 | CA2102142A1 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
09/30/1994 | CA2119995A1 Processes for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives |
09/30/1994 | CA2119531A1 Anti-inflammatory analgesic plaster |
09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
09/29/1994 | WO1994021764A1 Unsaponifiable materials of vegetable origin and cosmetic compositions containing same |
09/29/1994 | WO1994021689A1 Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity |
09/29/1994 | WO1994021667A1 Compound for inhibiting bone resorption and accelerating osteogenesis |
09/29/1994 | WO1994021651A1 Taxanes having furyl or thienyl substituted side-chain |
09/29/1994 | WO1994021649A1 Crystalline benzathine salt of cefonicid and its preparation |
09/29/1994 | WO1994021645A1 ENANTIOSELECTIVE SYNTHESIS OF 5,6-DIHYDRO-(S)-4-(ETHYLAMINO)-(S)-6-METHYL-4H-THIENO[2,3-b]THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE AND RELATED COMPOUNDS |
09/29/1994 | WO1994021644A1 Thio-heterocyclic macrolactam immunomodulators |
09/29/1994 | WO1994021643A1 Macrocyclic carbamate immunomodulators |
09/29/1994 | WO1994021642A1 Macrocyclic amide and urea immunomodulators |
09/29/1994 | WO1994021641A1 Process for production of an imidazole derivative |
09/29/1994 | WO1994021639A1 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
09/29/1994 | WO1994021633A1 Carbacephalosporin compound, their preparation and use |
09/29/1994 | WO1994021630A1 Antipsychotic indazole derivatives |
09/29/1994 | WO1994021629A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
09/29/1994 | WO1994021628A1 Indole derivatives as dopamine d4 antagonists |
09/29/1994 | WO1994021626A1 Indazole derivatives |
09/29/1994 | WO1994021625A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
09/29/1994 | WO1994021622A1 Method for purifying taxoids |
09/29/1994 | WO1994021619A1 Naphthalene derivatives |
09/29/1994 | WO1994021618A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same |
09/29/1994 | WO1994021616A1 Heterocycle-containing amidine derivatives, their preparation and use |
09/29/1994 | WO1994021615A1 Benzimidazole derivatives |
09/29/1994 | WO1994021611A1 Amide derivatives as 5-ht1a ligands |
09/29/1994 | WO1994021610A1 Piperazine derivatives as 5-ht1a ligands |
09/29/1994 | WO1994021608A1 Indoletetralins having dopaminergic activity |
09/29/1994 | WO1994021607A1 New heterocyclic compounds, their preparation and their use |
09/29/1994 | WO1994021604A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
09/29/1994 | WO1994021599A1 Novel compound with platelet aggregation inhibitor activity |
09/29/1994 | WO1994021595A1 Amine derivative and dermatologic preparation containing the same |
09/29/1994 | WO1994021590A1 Phenoxyphenylacetic acid derivatives |
09/29/1994 | WO1994021292A1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
09/29/1994 | WO1994021271A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
09/29/1994 | WO1994021269A1 Drugs for the treatment of retrovirus infections |
09/29/1994 | WO1994021268A1 Aluminium containing pharmaceutical preparation with controlled release |
09/29/1994 | WO1994021267A1 Tylosin containing sustained release veterinary compositions |
09/29/1994 | WO1994021266A1 The use of bisphosphonates in bone surgery |
09/29/1994 | WO1994021265A1 Antineoplastic agents with improved efficiency |
09/29/1994 | WO1994021264A1 Use of glucocorticoids for treating and preventing aids, and compositions therefor containing same |
09/29/1994 | WO1994021263A1 Pharmaceutical composition in the form of a kit |
09/29/1994 | WO1994021262A1 Device for the transdermal administration of alprazolam |
09/29/1994 | WO1994021261A1 Use of triazine compounds as anxiolytics |
09/29/1994 | WO1994021260A1 Use of triazine compounds for the treatment of memory and learning disorders |
09/29/1994 | WO1994021258A1 Heterocycle-containing macrocyclic immunomodulators |
09/29/1994 | WO1994021257A1 Use of granisetron for the treatment of post-operative nausea and vomiting |
09/29/1994 | WO1994021256A1 Compositions for the treatment of eye diseases |
09/29/1994 | WO1994021254A1 Substituted alicyclic amine-containing macrocyclic immunomodulators |
09/29/1994 | WO1994021252A1 Taxanes having a pyridyl substituted side-chain |
09/29/1994 | WO1994021251A1 Taxanes having an amino substituted side-chain |
09/29/1994 | WO1994021250A1 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
09/29/1994 | WO1994021249A1 Arsenic medicaments for the treatment of the chronic asthenia syndrome |
09/29/1994 | WO1994021248A1 Use of substituted alkyl nitrates for the treatment of pathologically increased intra-ocular pressure |
09/29/1994 | WO1994021247A1 Use of cis-9-heptadecenoic acid for treating psoriasis, allergies and autoimmune diseases |
09/29/1994 | WO1994021246A1 Use of non-steroidal antiinflammatory agents in macular degeneration |
09/29/1994 | WO1994021245A1 Use of carnosine or a combination with urocanic acid for treatment of photodermatoses |
09/29/1994 | WO1994021244A1 Method of treating addictive behaviors |
09/29/1994 | WO1994021242A1 Methods for the treatment of osteoporosis |